Episode 81: San Antonio Breast Cancer Symposium Update

San Antonio Breast Cancer Symposium is here, and this year, OFTIM (Oncology for the Inquisitive Mind) is bringing you the latest and greatest in all things breast cancer. With over 10000 attendees, the research and vibrant discussions did not disappoint, with updates, controversies and complexities. Taking centre stage were PIK3CA mutation treatments, updates on CDK4/6 inhibitors and the age-old question - does exercise improve outcomes for our patients?

Studies discussed in today's episode (subscription may be required)

  • MONARCH-3

  • KATHERINE

  • INAVO120

  • PREFERABLE EFFECT

Previous
Previous

Fireside Chats 2. Time Toxicity in Early Phase Trials

Next
Next

Episode 80: ESMO 2023 - Plenary Session